RARE relationship map
RARE
Ultragenyx Pharmaceutical Inc.
RAREUltragenyx Pharmaceutical Inc.
—Kyowa Kirinunlisted
45.00% of RARE revRARE 10-K
—KKCunlisted
—Mereounlisted
—Omersunlisted
—RPI Finance Trustunlisted
Sells to →
Undisclosed supplierunnamed in filing
30.00% of RARE rev10-K
2°Medlineunlisted
2°ReproNovounlisted
2°Feng Biosciencesunlisted
2°Two distributor customersunnamed in filing
2°Nippon Shinyaku Co., Ltd. (Nippon Shinyaku)unlisted
2°Nippon Shinyakuunlisted
Abeonaunlisted—
Aenova Haupt Pharma Wolfratshausen GmbHunlisted—
Baylor Research Instituteunlisted—
BSP Pharmaceuticalsunlisted—
Catalent Marylandunlisted—
Catalent Maryland, Inc. and Catalent Pharma Solutions, LLC (collectively, Catalent)unlisted—
Catalent Pharma Solutionsunlisted—
IOI Oleo GmbHunlisted—
KKCunlisted—
Kyowa Kirinunlisted—
Rentschler Biopharmaunlisted—
Saint Louis Universityunlisted—
Solid Biosciencesunlisted—
University of Pennsylvaniaunlisted—
← Buys from
RAREUltragenyx Pharmaceutical Inc.
—Kyowa Kirinunlisted
45.00% of RARE rev10-K
—KKCunlisted
—Mereounlisted
—Omersunlisted
—RPI Finance Trustunlisted
Sells to →
suppliercustomerunlisted2°second-degree (Extended)
sector groupThick line = filed share ·Moves · 19:08 ETSources